S2209: Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM)
The study compares three-drug induction regimens followed by double or single-agent maintenance therapy for newly diagnosed multiple myeloma in frail or intermediate-fit patients.
Bizonyítékszint: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Kapcsolódó jelek
- Multiple Myeloma Clinical Trials & Emerging Therapies
- Improved survival in multiple myeloma following prior detection of precursor conditions: a nationwide real-world study
- Nanomedicine-Empowered CAR‑T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy
- Reaching Consensus on Defining, Treating High‑Risk Myeloma
- Toward a cure for multiple myeloma within a decade